FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BPC 157: Miracle Healing Peptide or Hidden Danger? FDA Moves to Reevaluate Several Peptides American Med Spa Association Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law